InspireMD, Inc. (NSPR) Bundle
Ever wondered who's investing in InspireMD Inc. (NSPR) and, more importantly, why? As of December 31, 2024, institutional investors held approximately 41.59% of the company's shares. Major players like Rosalind Advisors, Inc. held 2,495,783 shares, and Orbimed Advisors Llc maintained a significant position with 2,133,405 shares. But with InspireMD's full-year 2024 revenue reaching $7.01 million, a 13% increase from 2023, and a potential U.S. approval for their CGuard Prime stent system on the horizon, what's driving these investment decisions? Let's delve into the investor profile of InspireMD (NSPR) and uncover the motivations behind their investments.
InspireMD, Inc. (NSPR) Who Invests in InspireMD, Inc. (NSPR) and Why?
Understanding the investor profile of InspireMD, Inc. (NSPR) involves examining the diverse range of individuals and institutions that hold its stock. These investors are driven by various motivations and employ different investment strategies, reflecting their unique perspectives on the company's potential.
Key Investor Types:
The investor base of InspireMD, Inc. (NSPR) typically includes:
- Retail Investors: Individual investors who buy and sell shares for their own accounts. These investors may be attracted to InspireMD, Inc. (NSPR) due to its growth prospects or innovative technology.
- Institutional Investors: Entities such as mutual funds, pension funds, and insurance companies that invest on behalf of their clients. Their investment decisions are often based on in-depth research and analysis.
- Hedge Funds: Investment partnerships that use various strategies, including leverage and derivatives, to generate returns. They may invest in InspireMD, Inc. (NSPR) based on short-term trading opportunities or specific market events.
Investment Motivations:
Investors are drawn to InspireMD, Inc. (NSPR) for a variety of reasons:
- Growth Prospects: The potential for InspireMD, Inc. (NSPR) to expand its market share and increase its revenue is a significant motivator for many investors.
- Market Position: InspireMD, Inc. (NSPR)'s position within its industry and its competitive advantages can attract investors seeking stable, long-term growth.
Investment Strategies:
The strategies employed by investors in InspireMD, Inc. (NSPR) can vary widely:
- Long-Term Holding: Some investors adopt a buy-and-hold strategy, maintaining their positions for extended periods to benefit from the company's long-term growth.
- Short-Term Trading: Other investors engage in short-term trading, aiming to profit from short-term price fluctuations.
- Value Investing: Value investors seek to identify undervalued companies with the expectation that the market will eventually recognize their true worth.
To gain more insights into InspireMD, Inc. (NSPR)'s financial standing, consider exploring Breaking Down InspireMD, Inc. (NSPR) Financial Health: Key Insights for Investors.
InspireMD, Inc. (NSPR) Institutional Ownership and Major Shareholders
Understanding the institutional ownership and major shareholders of InspireMD, Inc. (NSPR) can provide valuable insights into the company's stock price, stability, and overall strategy. Institutional investors, such as mutual funds, hedge funds, and pension funds, often have significant resources and expertise to conduct in-depth research on companies. Their investment decisions can influence market perception and stock performance.
Information on major shareholders and institutional ownership can be found in various financial data sources. These sources compile data from regulatory filings, company reports, and other publicly available information to provide a snapshot of who owns InspireMD, Inc. (NSPR) shares.
Here's an overview of what to consider when analyzing InspireMD, Inc. (NSPR)'s investor profile:
- Top Institutional Investors: Identifying the largest institutional investors helps understand who has the most significant stake in the company.
- Changes in Ownership: Monitoring whether institutional investors are increasing or decreasing their positions can signal confidence or concern about the company's future prospects.
- Impact of Institutional Investors: Assessing the role these large investors play in the company's stock price and strategic decisions is crucial for a comprehensive understanding.
While specific, up-to-the-minute data on InspireMD, Inc. (NSPR)'s institutional ownership can fluctuate, examining recent trends and major players offers a glimpse into the investor sentiment surrounding the company.
For further insights into InspireMD, Inc. (NSPR)'s financial standing, explore: Breaking Down InspireMD, Inc. (NSPR) Financial Health: Key Insights for Investors
InspireMD, Inc. (NSPR) Key Investors and Their Impact on InspireMD, Inc. (NSPR)
Understanding the investor profile of InspireMD, Inc. (NSPR) is crucial for assessing the company's stability, growth potential, and overall market sentiment. Key investors can significantly influence company decisions and stock movements through their holdings and strategic actions.
Institutional Ownership:
As of April 2025, institutional investors hold a significant stake in InspireMD, Inc. (NSPR). According to Fintel, 33 institutional owners and shareholders have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC), holding a total of 12,759,163 shares. Nasdaq reports institutional ownership at 41.59%. Major institutions are defined as firms or individuals that exercise investment discretion over assets exceeding $100 million. These institutions include financial holdings companies, banks, insurance companies, mutual fund managers, portfolio managers, and self-managed pension and endowment funds.
Notable Investors:
Several key investors have significant positions in InspireMD, Inc. (NSPR):
- Rosalind Advisors, Inc.: One of the largest shareholders.
- Orbimed Advisors LLC: A prominent healthcare-focused investment firm.
- Marshall Wace, Llp: A leading global alternative investment manager.
- Nantahala Capital Management, LLC: Another key institutional investor.
- Soleus Capital Management, L.P.: A significant shareholder in the company.
- Velan Capital Investment Management LP: Holds a notable position.
- Parkman Healthcare Partners LLC: Specializes in healthcare investments.
- Pura Vida Investments, Llc: Focuses on investments in the healthcare sector.
- Millennium Management Llc: A large, diversified hedge fund.
- Affiance Financial, LLC: Another institutional investor with a stake in InspireMD, Inc. (NSPR).
Investor Influence:
The presence of these institutional investors can have a substantial impact on InspireMD, Inc. (NSPR). Their influence can manifest in several ways:
- Company Decisions: Large shareholders can influence strategic decisions, such as mergers, acquisitions, and significant capital investments.
- Stock Movements: Major purchases or sales by these investors can lead to significant fluctuations in the stock price.
- Corporate Governance: They can play a role in shaping corporate governance policies and executive compensation.
- Fund Sentiment Score: The Fund Sentiment Score reflects the degree to which funds are actively buying the stock.
Recent Moves:
Recent activity by key investors includes participation in private placements and adjustments to their holdings. For instance, in May 2023, InspireMD, Inc. (NSPR) announced a private placement of up to $113.6 million, led by Marshall Wace with participation from OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD, Inc. (NSPR) Board members. This included an initial upfront funding of $42.2 million.
Analyst Ratings and Price Targets:
Analysts' ratings and price targets also influence investor sentiment. As of April 2025, InspireMD, Inc. (NSPR) has a consensus rating of 'Strong Buy'. The average analyst price target is $5.00, representing a 92.31% increase from the current price of $2.60. This is based on the ratings from Wall Street analysts within the last three months. Specifically, analysts have issued 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings.
Financial Performance and Forecasts:
InspireMD, Inc. (NSPR)'s financial performance and future forecasts also play a crucial role in investor decisions. The company's revenue for 2024 was $7.01 million, a 12.96% increase compared to the previous year's $6.21 million. However, losses increased to -$32.01 million, 60.7% more than in 2023. The next quarter's earnings estimate is -$0.20 per share.
Additional Factors Influencing Investors:
- Market Capitalization: As of April 2025, InspireMD, Inc. (NSPR) has a market capitalization of approximately $77 million.
- Shareholder Dilution: Investors monitor potential shareholder dilution, which can impact the value of their holdings.
- Revenue Growth: Revenue is forecast to grow 57.46% per year.
- Risk Factors: Investors also consider risk factors, such as the company's limited operating history and dependence on regulatory approvals.
For more insights into the company's strategic direction, refer to Mission Statement, Vision, & Core Values of InspireMD, Inc. (NSPR).
InspireMD, Inc. (NSPR) Market Impact and Investor Sentiment
Understanding investor sentiment and market reactions to InspireMD, Inc. (NSPR) is crucial for current and potential shareholders. Analyzing major shareholder activity, recent market behavior, and analyst perspectives provides a comprehensive view of the stock's potential.
Investor sentiment towards InspireMD, Inc. (NSPR) can be gauged by monitoring the activity of major shareholders. Significant increases in holdings by institutional investors may indicate a positive outlook, while decreases could suggest concerns about the company's future performance. News articles, financial reports, and SEC filings (such as Form 4 filings for insider transactions and Schedule 13D/G filings for beneficial ownership) provide valuable insights into these ownership changes. Keep an eye on:
- Institutional Ownership: Track the percentage of shares held by institutions like mutual funds, hedge funds, and pension funds.
- Insider Transactions: Monitor purchases and sales by company executives and directors, as these can be strong indicators of their confidence in the company.
- Beneficial Ownership: Review filings by individuals or entities that own 5% or more of the company's shares.
The stock market's reaction to changes in ownership or large investor moves can offer immediate feedback on how the investment community views these developments. Positive reactions (i.e., a stock price increase) to news of increased institutional investment can reinforce positive sentiment, while negative reactions (i.e., a stock price decrease) to insider selling might signal concerns. Consider these factors:
- Trading Volume: High trading volume accompanying a price change can validate the significance of the move.
- Price Trends: Observe how the stock price behaves following major ownership changes. Is there a sustained upward or downward trend?
- Market Context: Consider overall market conditions and industry trends, as these can influence the stock's reaction to specific news events.
Analyst perspectives provide an informed view of how key investors might impact InspireMD, Inc. (NSPR)'s future. Analysts often conduct thorough research and build financial models to assess the potential consequences of ownership changes. Their insights can help investors understand the bigger picture. Look for:
- Analyst Ratings: Pay attention to ratings upgrades or downgrades, as well as target price revisions, following significant investor moves.
- Earnings Estimates: See if analysts revise their earnings estimates based on changes in the investor base.
- Rationale: Understand the reasoning behind analysts' opinions. What specific factors are they citing to support their views?
For example, if a well-respected healthcare-focused hedge fund initiates a large position in InspireMD, Inc. (NSPR), analysts might highlight the fund's expertise in the medical device industry and its potential to add value through strategic guidance or by attracting other institutional investors. Conversely, if a major shareholder with a history of short-term investing reduces their stake, analysts might express concerns about potential downward pressure on the stock price.
Here's a hypothetical example of how to track and interpret investor-related news:
Date | Event | Market Reaction | Analyst Perspective |
---|---|---|---|
2024-07-15 | Vanguard Group increases its stake in NSPR by 1.5% | Stock price rises by 3% on high volume | 'Vanguard's increased position reflects confidence in NSPR's long-term growth potential, particularly its MGuard Prime EPS device. We maintain our Buy rating with a target price of $3.50.' |
2024-08-01 | CEO sells 10% of their shares | Stock price falls by 5% | 'While insider selling can create short-term pressure, we believe the CEO's sale is for personal financial planning and does not reflect a change in the company's fundamentals. We are reiterating our Neutral rating.' |
2024-09-20 | Soros Fund Management discloses a new 6% stake in NSPR | Stock jumps by 10% | 'Soros Fund Management's investment signals strong conviction in NSPR's technology and market opportunity. This could attract further institutional interest and drive the stock higher. We are upgrading our rating to Outperform with a new target price of $4.00.' |
Staying informed about these dynamics can provide a more nuanced understanding of InspireMD, Inc. (NSPR)'s market behavior and potential investment opportunities. Detailed insights into InspireMD, Inc. (NSPR)'s financial standing can be found at: Breaking Down InspireMD, Inc. (NSPR) Financial Health: Key Insights for Investors
InspireMD, Inc. (NSPR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.